Urology
Volume 75, Issue 5 , Page 1114, May 2010

Editorial Comment

Division of Hematology-Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(09)02389-9

doi:10.1016/j.urology.2009.07.1290

Refers to article:

  • The Loss of Radiographic Enhancement in Primary Renal Cell Carcinoma Tumors Following Multitargeted Receptor Tyrosine Kinase Therapy is an Additional Indicator of Response , 20 November 2009

    C. Lance Cowey, Julia R. Fielding, W. Kimryn Rathmell
    Urology May 2010 (Vol. 75, Issue 5, Pages 1108-1113.e1)

Urology
Volume 75, Issue 5 , Page 1114, May 2010

Article Tools